Skip to main content
. 2010 Jan 5;3(1):10–18. doi: 10.3390/ph3010010

Table 2.

Oral provocation tests with acetylsalicylic acid (ASA).

Patients with respiratory symptoms (AERD)
Hour Day 1 Day 2 Day 3
08:00 Placebo ASA 3 or 30 mg ASA 150 mg
11:00 Placebo ASA 60 mg ASA 325 mg
14:00 Placebo ASA 100 mg ASA 650 mg
Monitor pulmonary function, naso-ocular symptoms/signs
Test positive if a decrease of FEV1 ° 20 % is observed
Patients with urticaria and/or angioedema
08:00 Placebo ASA 100 mg ASA 325 mg
10:00 Placebo ASA 200 mg ASA 650 mg
Skin scores recorded every 2 hours